Frese, Kristopher K <br/><br/>
nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer.  [electronic resource] 

 -  Cancer discovery  Mar 2012 
 - 260-269 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2159-8290 
<br/><br/><label>Standard No.: </label>10.1158/2159-8290.CD-11-0242  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Albumins--administration & dosage<br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Carcinoma, Pancreatic Ductal--drug therapy<br/>Cytidine Deaminase--metabolism<br/>Deoxycytidine--administration & dosage<br/>Disease Models, Animal<br/>Drug Synergism<br/>Mice<br/>Paclitaxel--administration & dosage<br/>Pancreatic Neoplasms--drug therapy<br/>Gemcitabine